Nanoparticle‑based antiviral strategies to combat the influenza virus (Review).

Autor: Rios-Ibarra CP; Medical and Pharmaceutical Biotechnology Unit, Center for Research and Assistance in Technology and Design of The State of Jalisco (CIATEJ), Guadalajara, Jalisco 44270, Mexico., Salinas-Santander M; Research Department, School of Medicine Saltillo, Universidad Autonoma de Coahuila, Unidad Saltillo, Coahuila 25000, Mexico., Orozco-Nunnelly DA; Department of Biology, Valparaiso University, Valparaiso, IN 46383-6493, USA., Bravo-Madrigal J; Medical and Pharmaceutical Biotechnology Unit, Center for Research and Assistance in Technology and Design of The State of Jalisco (CIATEJ), Guadalajara, Jalisco 44270, Mexico.
Jazyk: angličtina
Zdroj: Biomedical reports [Biomed Rep] 2024 Feb 21; Vol. 20 (4), pp. 65. Date of Electronic Publication: 2024 Feb 21 (Print Publication: 2024).
DOI: 10.3892/br.2024.1753
Abstrakt: The rapid availability of effective antiviral treatments would be beneficial during the early phases of a pandemic, as they could reduce viral loads and control serious infections until antigenic vaccines become widely available. One promising alternative therapy to combat pandemics is nanotechnology, which has the potential to inhibit a wide variety of viruses, including the influenza virus. This review summarizes the recent progress using gold, copper, silver, silicone, zinc and selenium nanoparticles, since these materials have shown remarkable antiviral capacity against influenza A virus.
Competing Interests: The authors declare that they have no competing interests.
(Copyright: © 2024 Rios-Ibarra et al.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje